Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| -100.0% |
| Open the original filing on SEC.gov |
| Nov 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,500 | $106.05 | $265.1K | -92.6% | Open the original filing on SEC.gov |
| Nov 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 10,765 | $105.31 | $1.1M | -80.0% | Open the original filing on SEC.gov |
| Nov 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,039 | $104.16 | $212.4K | -13.2% | Open the original filing on SEC.gov |
| Nov 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,300 | $103.09 | $134K | -7.7% | Open the original filing on SEC.gov |
| Nov 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,196 | $102.10 | $122.1K | -6.6% | Open the original filing on SEC.gov |
| Nov 12 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 18,000 | $6.84 | $123.1K | — | Open the original filing on SEC.gov |
| Oct 14 | ELVN | Enliven Therapeutics, Inc. | AGRANT◆ | 23,394 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 9,136 | — | — | — | Open the original filing on SEC.gov |
| Jun 2, 2025 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |